Peter Schmid-Grendelmeier Selected Research

mepolizumab

1/2021	Eosinophil-mast cell interaction: Mepolizumab leads to a reduction of clinical symptoms and serum tryptase in a patient with eosinophilic asthma and idiopathic mast cell activation.
1/2021	Real-Life Experience of Monoclonal Antibody Treatments in Chronic Rhinosinusitis with Nasal Polyposis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Schmid-Grendelmeier Research Topics

Disease

29	Hypersensitivity (Allergy) 06/2022 - 06/2003
23	Atopic Dermatitis (Atopic Eczema) 06/2022 - 07/2002
19	Asthma (Bronchial Asthma) 10/2022 - 02/2002
7	Inflammation (Inflammations) 01/2021 - 07/2003
6	Eosinophilia 01/2022 - 09/2002
5	Urticaria (Hives) 01/2021 - 09/2012
5	Chronic Urticaria 01/2021 - 09/2012
4	Bites and Stings (Sting) 06/2022 - 01/2013
4	Anaphylaxis (Anaphylactic Shock) 06/2022 - 07/2019
4	COVID-19 01/2022 - 01/2020
4	Eczema 12/2021 - 01/2007
4	Rhinosinusitis 01/2021 - 07/2009
4	Seasonal Allergic Rhinitis (Hay Fever) 01/2014 - 06/2003
3	Mastocytosis 06/2022 - 07/2019
3	Drug Hypersensitivity (Drug Allergy) 01/2022 - 07/2019
3	Skin Diseases (Skin Disease) 01/2017 - 02/2012
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2011 - 01/2006
2	Exanthema (Rash) 01/2022 - 02/2012
2	Fever (Fevers) 01/2021 - 10/2016
2	Nasal Polyps (Nasal Polyp) 01/2020 - 07/2002
2	Angioedema 01/2018 - 08/2010
2	Allergic Contact Dermatitis 01/2017 - 02/2012
2	Rhinitis 04/2016 - 01/2016
2	Allergic Rhinitis 04/2016 - 01/2014
2	Food Hypersensitivity (Food Allergy) 10/2013 - 06/2003
2	Respiratory Tract Diseases (Respiratory Tract Disease) 04/2010 - 01/2007
2	Pruritus (Itching) 01/2010 - 10/2006
2	Hypereosinophilic Syndrome (Loeffler Endocarditis) 09/2002 - 07/2002
1	Heart Arrest (Cardiac Arrest) 06/2022
1	Acne Vulgaris 06/2022
1	Cryopyrin-Associated Periodic Syndromes 01/2021
1	Vasculitis (Vasculitides) 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Infections 01/2020
1	Systemic Mastocytosis 01/2020
1	Vertigo (Positional Vertigo) 01/2020
1	Dizziness (Lightheadedness) 01/2020
1	Diarrhea 01/2020
1	congenital Sucrase-isomaltase deficiency 07/2019
1	Mast Cell Activation Disorders (Mast-Cell Disease) 07/2019
1	Immediate Hypersensitivity 11/2018

Drug/Important Bio-Agent (IBA)

26	Immunoglobulin E (IgE)IBA 01/2021 - 05/2005
16	AllergensIBA 01/2021 - 06/2003
8	Pharmaceutical PreparationsIBA 01/2022 - 10/2006
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2003
5	VenomsIBA 06/2022 - 01/2013
5	benralizumabIBA 01/2021 - 01/2019
5	Biological ProductsIBA 01/2021 - 11/2012
5	Omalizumab (Xolair)FDA Link 01/2021 - 06/2012
5	CytokinesIBA 04/2010 - 02/2002
4	Monoclonal AntibodiesIBA 01/2021 - 01/2019
4	SteroidsIBA 01/2021 - 01/2010
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 12/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 01/2013
3	Histamine (Histamine Dihydrochloride)FDA Link 06/2022 - 07/2019
3	Filaggrin ProteinsIBA 10/2021 - 01/2007
3	Interleukin-5 (Interleukin 5)IBA 01/2021 - 01/2019
3	dupilumabIBA 01/2021 - 01/2021
3	Wasp Venoms (Venom, Wasp)IBA 01/2021 - 01/2013
3	anti-IgE antibodiesIBA 01/2020 - 02/2018
3	EnzymesIBA 07/2019 - 05/2005
3	Arthropod VenomsIBA 01/2019 - 01/2013
3	VaccinesIBA 11/2012 - 02/2005
2	Bee Venoms (Bee Venom)IBA 06/2022 - 01/2013
2	Tryptases (Tryptase)IBA 01/2021 - 01/2019
2	Interleukin-4 (Interleukin 4)IBA 01/2021 - 11/2010
2	Histamine Antagonists (Antihistamines)IBA 01/2021 - 01/2013
2	mepolizumabIBA 01/2021 - 01/2021
2	Interleukin-13IBA 01/2021 - 07/2002
2	Immunoglobulin G (IgG)IBA 12/2019 - 10/2016
2	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2019 - 01/2019
2	AntibodiesIBA 01/2019 - 08/2009
2	ThioredoxinsIBA 01/2007 - 03/2006
2	ChemokinesIBA 01/2005 - 07/2003
1	Environmental BiomarkersIBA 10/2022
1	Janus Kinase 1IBA 06/2022
1	EmollientsIBA 01/2022
1	beta Lactam AntibioticsIBA 11/2021
1	beta-LactamsIBA 11/2021
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 01/2021
1	InterleukinsIBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	SolutionsIBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2021
1	canakinumab FDA Link 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2020
1	AutoantibodiesIBA 12/2019
1	Starch (Cornstarch)IBA 07/2019
1	Oxidoreductases (Dehydrogenase)IBA 07/2019
1	AminesIBA 07/2019
1	SugarsIBA 07/2019
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 07/2019
1	Antidepressive Agents (Antidepressants)IBA 07/2019
1	Catechol O-Methyltransferase InhibitorsIBA 07/2019

Therapy/Procedure

11	Therapeutics 01/2021 - 03/2002
8	Immunotherapy 06/2022 - 03/2006
4	Precision Medicine 01/2021 - 01/2016
2	Injections 01/2014 - 03/2002
1	Cardiopulmonary Resuscitation (CPR) 06/2022
1	Organ Transplantation 01/2020